- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 18.62M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 19.7M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $147M |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $223.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $225M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $2.2M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $500K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.93B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.89B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.62B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.5B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.22B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.56B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.04B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.38B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.62B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $9.87 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $6.71 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $9.90 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $6.73 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $510.4M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $456.4M |
| Net Income | Q1 2026 · Mar 31, 2026 | $187.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | $132.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $193.9M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $234.3M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $726.9M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $724.2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.39B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.42B |